Baseline and clinical characteristics | |||
Characteristics | Direct (n=59) | Transfer (n=154) | P value |
Age (median, years) | 74 (35–96) | 76 (29–95) | 0.66 |
Female | 26 (44.1%) | 74 (48.1%) | 0.60 |
NIHSS score, median | 18 (1–34) | 17 (2–42) | 0.32 |
Medical history | |||
Hypertension | 40 (67.8%) | 108 (70.1%) | 0.74 |
Ischaemic heart disease | 17 (28.8%) | 42 (27.3%) | 0.82 |
Atrial fibrillation | 27 (45.8%) | 75 (48.7%) | 0.70 |
Diabetes | 16 (27.1%) | 35 (22.7%) | 0.50 |
Dyslipidaemia | 35 (59.3%) | 85 (55.2%) | 0.59 |
Previous stroke | 13 (22.0%) | 25 (16.2%) | 0.32 |
Smoking | 15 (25.4%) | 23 (14.9%) | 0.07 |
Treatment | |||
IVT | 21 (35.6%) | 61 (39.6%) | 0.59 |
GA | 59 (100.0%) | 153 (99.4%) | 0.54 |
Location of thrombus | 0.39 | ||
M1 | 31 (52.5%) | 88 (57.1%) | |
M2 | 14 (23.7%) | 23 (14.9%) | |
ICA | 8 (13.6%) | 19 (12.3%) | |
Tandem | 6 (10.2%) | 24 (15.6%) | |
Baseline mRS score | 0.96 | ||
0–2 | 57 (96.6%) | 149 (96.8%) | |
≥3 | 2 (3.4%) | 5 (3.3%) |
GA, general anaesthesia; ICA, internal carotid artery; IVT, intravenous thrombolysis; M1, segment 1 of the middle cerebral artery; M2, segment 2 of the middle cerebral artery; mRS, modified Rankin Scale; NIHSS, National Institutes of Health Stroke Scale; Tandem, cervical ICA and M1 or M2.